Category - Bussnis
DGAP-Information: Smartbroker Holding AG publishes preliminary half-year figures for 2022 – 1H consequence on track regardless of troublesome market scenario | 24.08.22
Agility has completed its £763m acquisition of Menzies Aviation
Greiner participates in the launch of the MATR circular economy
As expected, Zalando is hit by a drop in consumption
DGAP-News: With enormous growth momentum in the first half of the year, BayWa AG raises annual forecast to EUR 400-450 million | 08/04/22
COBIN claims: Initiation of action for those affected by CPI insolvency – case much ‘bigger’ than Wienwert
Börse Express – Bee Vectoring Technology secures the first order from California from a grower of a major global berry producer
Jubilant Therapeutics Inc. announces that the US FDA has approved an IND for JBI-778, an orally administered, brain-penetrating and selective inhibitor of PRMT5, for the treatment of solid tumors with brain metastases and primary brain tumors.